Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5
- 20 May 2004
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 319 (2) , 397-404
- https://doi.org/10.1016/j.bbrc.2004.05.003
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- APOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart diseaseJournal of Lipid Research, 2004
- Association found between the promoter region polymorphism in the apolipoprotein A-V gene and the serum triglyceride level in Japanese schoolchildrenHuman Genetics, 2002
- Apolipoprotein A-VJournal of Biological Chemistry, 2001
- An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative SequencingScience, 2001
- Both Lipolysis and Hepatic Uptake of VLDL Are Impaired in Transgenic Mice Coexpressing Human Apolipoprotein E*3Leiden and Human Apolipoprotein C1Arteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Triglyceride-rich lipoproteins and the progression of coronary artery diseaseCurrent Opinion in Lipidology, 1995
- Modulation of Lipoprotein B Binding to the LDL Receptor by Exogenous Lipids and Apolipoproteins CI, CII, CIII, and EArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles.Journal of Clinical Investigation, 1992
- Effect of apoproteins on hepatic uptake of triglyceride emulsions in the rat.Journal of Clinical Investigation, 1980
- Effect of serum and C‐apoproteins from very low density lipoproteins on human postheparin plasma hepatic lipaseFEBS Letters, 1976